Weitering J G, Mulder G J, Meijer D K, Lammers W, Veenhuis M, Bonga S E
Naunyn Schmiedebergs Arch Pharmacol. 1975;289(3):251-6. doi: 10.1007/BF00499979.
After i.v. injection in the rat, d-tubocurarine is taken up and concentrated by the liver. A method is developed for the visualisation of d-tubocurarine inside the liver cell by electron microscopy. Glutaraldehyde fixed liver blocks were immersed in an ammonium molybdate solution; d-tubocurarine was precipitated at sites of high concentration by molybdate, to form an insoluble d-tubocurarine-molybdate complex. This precipitate was found predominantly at the surface of lysosome-like particles, but also inside these organelles. In subcellular fractionation experiments, d-tubocurarine was found with a high relative specific "activity" in the lysosomal fraction, lending support to a lysosomal localisation of d-tubocurarine.
给大鼠静脉注射后,d - 筒箭毒碱被肝脏摄取并浓缩。开发了一种通过电子显微镜观察肝细胞内d - 筒箭毒碱的方法。将戊二醛固定的肝块浸入钼酸铵溶液中;d - 筒箭毒碱在高浓度部位被钼酸盐沉淀,形成不溶性的d - 筒箭毒碱 - 钼酸盐复合物。这种沉淀物主要在溶酶体样颗粒的表面发现,但也在这些细胞器内部。在亚细胞分级分离实验中,发现d - 筒箭毒碱在溶酶体分级中具有较高的相对比“活性”,这支持了d - 筒箭毒碱在溶酶体中的定位。